Natus Medical Inc (NASDAQ:BABY)
| 14.05 Data as of May 22 |  -1.06 / -7.02%Today’s Change | 9.65 Today|||52-Week Range 15.18 | +25.85% Year-to-Date |
Latest BABY News | Press Releases
| Volcano Product Launch at EuroPCR - Analyst Blog May 21 / Zacks.com | Alleged Patent Infringement by BSX - Analyst Blog May 17 / Zacks.com |
| Natus Medical Beats on Both Top and Bottom Lines May 20 / MotleyFool.com | Neutral Rating Restated for Cepheid - Analyst Blog May 13 / Zacks.com |
Today’s Trading
| Previous close | 15.11 |
| Today’s open | 15.18 |
| Day’s range | -- - -- |
| Volume | 377,920 |
| Average volume (3 months) | 126,273 |
| Market cap | $458.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +34.19% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +25.63% |
| P/E ratio | 108.1 |
| Price/Sales | 1.11 |
| Price/Book | 1.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CSIICardiovascular Syste... | -1.00 | -5.34% |
| SQNMSequenom Inc | -0.15 | -3.69% |
| MMSIMerit Medical System... | -0.11 | -1.09% |
| ATRIAtrion Corp | +0.02 | +0.01% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $292.3M |
| Annual profit (last year) | $3.9M |
| Net profit margin | 1.33% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President & Chief Operating Officer John T. Buhler |
Chief Executive Officer & Director James B. Hawkins, MBA |
Corporate headquarters San Carlos, California |
Forecasts
